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Abstract
Background: The NF-κB regulatory network controls innate immune response by transducing
variety of pathogen-derived and cytokine stimuli into well defined single-cell gene regulatory
events.
Results: We analyze the network by means of the model combining a deterministic description
for molecular species with large cellular concentrations with two classes of stochastic switches:
cell-surface receptor activation by TNFα ligand, and IκBα and A20 genes activation by NF-κB
molecules. Both stochastic switches are associated with amplification pathways capable of
translating single molecular events into tens of thousands of synthesized or degraded proteins.
Here, we show that at a low TNFα dose only a fraction of cells are activated, but in these activated
cells the amplification mechanisms assure that the amplitude of NF-κB nuclear translocation
remains above a threshold. Similarly, the lower nuclear NF-κB concentration only reduces the
probability of gene activation, but does not reduce gene expression of those responding.
Conclusion: These two effects provide a particular stochastic robustness in cell regulation,
allowing cells to respond differently to the same stimuli, but causing their individual responses to
be unequivocal. Both effects are likely to be crucial in the early immune response: Diversity in cell
responses causes that the tissue defense is harder to overcome by relatively simple programs
coded in viruses and other pathogens. The more focused single-cell responses help cells to choose
their individual fates such as apoptosis or proliferation. The model supports the hypothesis that
binding of single TNFα ligands is sufficient to induce massive NF-κB translocation and activation of
NF-κB dependent genes.
Background
Living cells are considered noisy or stochastic biochemical
reactors. Most of the cell to cell variability is due to exist-
ence of stochastic switches or slow reaction channels
involving limited numbers of reacting molecules. Stochas-
tic switches provide inputs for amplification cascades,
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population of downstream effector molecules.
The most studied example of stochastic regulation is gene
expression, where stochasticity, in eukaryotic organisms,
arises mostly from fluctuation in gene activity [1-5] and
mRNA synthesis or decay [6-10] reviewed recently in [11].
Control of gene activity is mediated by transcription fac-
tors that bind to specific promoter regions, switching the
gene on or off. When the gene is active, RNA polymerase
may bind to the gene promoter and enter the transcrip-
tional elongation mode, producing full length pre-mRNA
transcripts. The edited mRNA is then exported to the cyto-
plasm, where the protein translation occurs. In this way, a
single gene activation event results (if the activation
period is sufficiently long) in a burst of mRNA molecules
[12], which is then translated into an even larger burst of
proteins.
Another example of stochastic regulation is provided by
cell surface receptors and amplification of successive cas-
cade of downstream kinases. There is a large body of evi-
dence that cells are capable of responding to a single- or a
very limited number of activating molecules. For example,
retinal Rod cells are able to transduce a single photon into
a hyperpolarization response [13]. For the present study,
signal amplification from a small number of receptors
detecting pathogen presence is specially important since it
enables cells to respond with protective cytokine cascades
to protect the tissue before adaptive immune response can
be generated. For example, T-lymphocytes are able to
detect a single foreign peptide antigen and only three pep-
tides are required for induction of T-cell cytotoxicity
[14,15]. Similar behavior is seen for the toll-interleukin
(TIR) superfamily of receptors, where IL-1 signal transduc-
tion has been observed in cells expressing only about 10
IL-1 receptors per cell [16]. Similarly, cells respond to
TNFα stimulation at femtomolar concentration, i.e.,
when the number of TNFα ligands per cell is very limited
[17]. In all cases, the activation of receptors leads to the
initiation of a signal transduction-amplification cascade,
involving activation (phosphorylation) of downstream
effector kinases. More generally, it is important to point
out that cells can detect and respond to single molecule
intracellular events such as DNA damage (leading to p53
activation) or presence of single viral RNAs. Although the
phenomenon of cell sensitivity to single activating mole-
cules is well established in biological systems, very few
theoretical studies have addressed the effect of stochastic
cell surface signaling and its consequences for the down-
stream cellular responses.
Innate immunity is an intensively studied cellular signal-
ing response to pathogens and pathogen-associated pat-
terns which results in the expression of protective
cytokines, such as interferon β, that serve to limit the
spread of infection until more specific adaptive immunity
can be generated. In this regard, the cytoplasmic transcrip-
tion factor NF-κB is a major mediator of innate immune
responses [18,19]. In resting cells NF-κB is sequestered in
the cytoplasm by dimerization with inhibitory proteins
called IκB. Although several IκB isoforms have been iden-
tified, the primary inhibitor is IκBα. In the classical NF-κB
activation pathway, extracellular signals such as tumor
necrosis factor-alpha (TNFα) and interleukin-1 (IL-1)
bind to cell surface receptors coupled to the cytoplasmic
IκB kinase (IKK), a multiprotein complex that phosphor-
ylates IκBα, leading to its ubiquitination and then to its
rapid proteasomal degradation [20]. Liberated NF-κB is
then rapidly translocated into the nucleus to bind to high
affinity sites in the genome, thereby influencing target
gene expression. Experimental findings have shown that
NF-κB nuclear residence is transient and dynamic, an
observation that has led to the discovery of negative feed-
back NF-κB-IκBα loop in the NF-κB pathway [21].
The two levels of autoregulatory negative feedback con-
trol, termed the NF-κB-IκBα and NF-κB-A20-IKK feedback
loops, arise because both IκBα and A20 genes are directly
regulated by NF-κB binding. In the NF-κB-IκBα feedback
loop, NF-κB enters the nucleus after IκBα degradation,
NF-κB induces IκBα resynthesis to recapture activated
nuclear NF-κB and return it to the cytoplasm. In the NF-
κB-A20-IKK feedback loop, A20, a protein that is not
expressed prior to stimulation is also strongly NF-κB
responsive [22]. A20 is an inhibitor of IKK kinase that
complexes with an IKK regulatory subunit leading to its
inactivation and that induces degradation of RIP a neces-
sary component of the active TNFR1 receptor complex.
Without A20 expression, the IKK retains activity which
leads to rapid degradation of the newly resynthesized
IκBα, which destroys the NF-κB-IκBα feedback loop [23].
As an illustration, genetically A20 deficient mice are
hypersensitive to TNFα and develop severe in inflamma-
tion even though they have an intact IκBα mRNA expres-
sion [24].
Nuclear NF-κB activates groups of genes through a process
initiated by its binding to high affinity DNA binding sites
in regulatory regions of their promoters. Although NF-κB
binding to some genes results in rate-limiting complex
formation of coactivators, pre-initiation factors, and RNA
polymerase (Pol) II, the mode of regulation of rapidly
induced negative feedback inhibitors appears to be dis-
tinct. Interestingly, chromatin immunoprecipitation
assays have shown that the IκBα and A20 promoters are
"pre-loaded"- already bound by general transcription fac-
tors, coactivators and RNA Pol II, waiting for the presence
of NF-κB binding to activate expression [25,26]. In these
promoters, RNA Pol II is stalled in an activated state; uponPage 2 of 20
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tional elongation mode and becomes able to transcribe
the gene. In this manner, the inhibitory genes of the NF-
κB feedback loop are poised to rapidly respond to the
presence of nuclear NF-κB.
In last five years several models of the NF-κB signaling reg-
ulatory module have been developed, reviewed in [27].
The first attempt was a one-feedback loop model that con-
centrated on the interplay between the three IκB isoforms
[28]. The next attempt was our two feedback loop model
[23], incorporating effects of both the IκBα and A20
inhibitors. In this model the representation of the NF-κB-
IκB regulatory module was simplified by incorporation of
only one IκB inhibitor, IκBα, that is responsible for the
majority of cytoplasmic NF-κB binding and the only one
which knockout is lethal, [29]. Incorporating the second
NF-κB-A20-IKK negative feedback loop, accurately pre-
dicted the time dependent profile of IKK activity. A third
model introduced the transduction pathway, from the
TNFR1 receptor to activation of the IKKK and IKK kinases
and was used to analyze responses of HepG2 cells and
HepG2.2.15 (HepG2 cells producing hepatitis B virus) to
TNFα stimulation [30].
Recently, the NF-κB signaling in single cells was analyzed
both experimentally [31-34] and numerically by means of
stochastic modeling [35,36], or agent-based modeling
[37]. Both analyses indicate that the NF-κB regulatory
module demands single cell, stochastic analysis due to
cellular heterogeneity and population asynchrony. In the
present work we expand our two-feedback loop, single-
cell stochastic model of NF-κB activation to incorporate a
second stochastic switch at the level of the TNFα-TNFR1
interaction. We analyze response of the NF-κB regulatory
module over a broad range of stimulation by its activating
ligand. We will show, how, although this may seem coun-
ter-intuitive, stochasticity and stochastic switches may
introduce robustness into the gene regulatory response. In
short, the stochastic robustness is due to amplification
cascades and progressive signal saturation. As a result, a
low amplitude signal (small concentration of activating
ligand or transcription factor) leads to an "almost" Yes or
No response, with the probability of Yes being a function
of the input signal amplitude. This type of regulation ena-
bles cells to chose a well-defined fate such as signaling,
apoptosis, or others, but in addition it allows individual
cell responses to vary. In the range of stimulation ampli-
tudes, for which most cells follow the same evolution
path, the cell population-based experiments and mode-
ling are well justified. However, in the case when popula-
tion is a mixture of differently responding cells (for
example apoptotic and proliferating or TNFα responding
or not) the average trajectory does not represent any bio-
logical process and the model reproducing such trajectory
is likely to be incorrect.
Results and discussion
Stochastic switches and amplification cascades in NF-κB 
regulation
Our considerations are based on the two-feedback loop
stochastic model of the NF-κB pathway, which combines
the signal transduction cascade that connects cell surface
receptors with the core regulatory module analyzed previ-
ously [35]. Current model involves two-compartment
kinetics of transcription factor NF-κB, its activators, IKKK,
IKK and inhibitors, A20 and IκBα, shown in Fig. 1. IKKK
represents the IKK activating kinase, which itself is acti-
vated at the TNFR1 receptor complex (see Materials and
Methods for details).
In Additional file 3 (Figs S1, S2, S3 and S4) we demon-
strate the model's ability to reproduce major NF-κB path-
way experiments on cells exhibiting oscillations in
cytoplasmic to nuclear NF-κB localization that arise in
response to persistent TNFα stimulation.
Two feedback-loop model of NF-κB regulatory pathwayFigur  1
Two feedback-loop model of NF-κB regulatory pathway.Page 3 of 20
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initiated by binding of TNFα to the ubiquitous receptor
TNFR1. In short, the action of regulatory pathway may be
summarized as follows: Binding of TNFα trimer initiates
receptor TNFR1 trimerization and formation of an active
receptor complex in a multistep process involving binding
of RIP and TRAF2. The active receptor complex activates
the IKKK kinase (transformation from IKKKn to IKKKa).
Active kinase IKKKa phosphorylates and activates the IKK
kinase (transformation from IKKn to IKKa). Active IKKa
kinase transiently binds to the cytoplasmic (NF-κB|IκBα)
complex and phosphorylates IκBα initiating its degrada-
tion. Released NF-κB enters the nucleus to induce tran-
scription of inhibitors IκBα and A20 genes. The first
negative feedback loop involves the IκBα protein, which
is rapidly resynthesized, enters the nucleus and recaptures
NF-κB back into the cytoplasm. In the continued presence
of IKKa, however, the resynthesized IκBα would be con-
tinuously degraded, which would result in continued
nuclear NF-κB translocation. A second level of negative
autoregulation occurs with the resynthesis of A20, a ubiq-
uitin ligase which controls IKK activity. A20 initiates deg-
radation of RIP, the key component of TNFR1 receptor
complex, what attenuates the activity of receptors and
directly associates itself with IKKa, enhancing its conver-
sion to catalytically inactive IKKi. Inactive kinase IKKi
spontaneously converts back to IKKn through the inter-
mediate form IKKii. Similarly, active kinase IKKKa rapidly
converts to the inactive form IKKKn.
We identified two stochastic processes crucial to the func-
tioning of the NF-κB regulatory pathway: (1) Activation of
A20 and IκBα genes via binding of NF-κB molecules to
the genes promoters and (2) activation of TNFR1 recep-
tors via binding of TNFα trimers. These stochastic events
may influence the evolution and fate of the cell due to
their association with amplification cascades, as shown in
Fig. 2 (see [38-40] for discussion of signal and noise prop-
agation in gene neworks and amplification cascades).
Gene expression cascade (Fig. 2A) starts from the activa-
tion of a single gene copy, which may then serve as a tem-
plate for the synthesis of tens or hundreds of mRNA
molecules. In turn, a single mRNA molecule is a template
for synthesis of hundreds of protein molecules. In this
way the two IκBα gene copies are sufficient to replenish
pool of IκBα proteins of about 100,000 molecules, within
a half hour. As estimated experimentally by Yang [41] the
endogenous level of IκBα molecules is 135,000, most of
these molecules are degraded at in first 10 min. of high
dose TNFα stimulation, and then IκBα level is approxi-
mately restored between 30 and 75 min. of stimulation
[28].
At the level of cell surface receptors, a single TNFα trimer
binding to the TNFR1 receptor leads to receptor trimeriza-
tion and formation of a stable active receptor complex
(Fig 2B). Grell [17] found that TNFα trimers dissociate
from TNFR1 receptors with a half time of 33 min., while
the internalization time is of order of 10 to 20 min. Dur-
ing this time the single active receptor may activate
numerous IKKK kinase molecules. In turn, each active
IKKKa activates numerous IKK kinases, and each of IKKa
may phosphorylate several IκBα molecules leading to
their degradation. The IKKK-IKK transduction cascade
resembles the MAPK cascade and provides signal ampli-
fica-tion of several orders of magnitude [42]. This ampli-
fication mechanisms enables cells to respond to
femtomolar concentrations of TNFα [17,43-45] and refer-
ences therein.
Recently, in cell population studies, Cheong et al. [45]
observed activation of the NF-κB regulatory module in
response to TNFα concentrations of 0.01 ng/ml. This
equals to 200 fM (assuming that TNFα consists of trimers
of mass 51 kDa) and implies about 1 TNFα trimer per 8 ×
10-12l or less than one TNFα trimer molecule per volume
of mammalian cell which is of the order 2 × 10-12l. This
estimations suggests that cells may be activated by bind-
ing of a single, or few, TNFα trimers, and that at femtomo-
lar concentration some cells may become active and some
not, since TNFα binding is a stochastic process. It also
indicates that when such small concentrations are consid-
ered, the average number of TNFα trimers per cell may be
a better parameter to describe the experiment than the
TNFα concentration itself. For example Chan and Aggar-
wal [44] observed two fold NF-κB induction at TNFα dose
of 100 fM. For the EMSA assay they incubated 2 × 106 cells
Two ways of signal amplification present in the modelFigure 2
Two ways of signal amplification present in the model. Panel 
A: A20 (or IκBα) gene expression. Panel B: Transduction 
amplification pathway leading to IκBα degradation.Page 4 of 20
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same concentration in tissue, where the cells are tightly
packed would imply less than 1 molecule of activator per
cell. The number of TNFR1 receptors per cell may vary sig-
nificantly between cell lines [44], e.g. there are about 3000
TNFR1 per cell for HeLa [17], and about 10000 for Histi-
ocytic lymphoma (U-937) cells [44], but much less for B-
cell lymphoma (Raji) cells. Since in low dose experiments
there are more TNFR1 receptors, than TNFα molecules,
the concentration of free TNFα will be influenced by reac-
tion with these receptors and will not remain constant in
the course of low dose experiments. Similarly, when the
spread of TNFα in the tissue is considered one may expect
that TNFα diffusion will be strongly influenced by bind-
ing to free TNFR1 receptors, which may restrict cell to cell
signaling to very short distances.
In HL60 cells, NF-κB activity was already observed at
TNFα concentrations as low as 0.1 pM whereas maximum
NF-κB activation required 0.4 to 2 pM TNFα, [43].
There is also an ample evidence that cells are able to
respond to single viruses, which are known to activate NF-
κB pathway through Toll-like receptors dependent and
independent pathways, both engaging IKK, [46,47]. Spe-
cifically, in a recent analysis of human A549 pulmonary
type II epithelial cells infected by respiratory syncytial
virus (RSV) at MOI = 1 (multiplicity of infection) we
showed that 60% of cell exhibit RelA activation [48]. The
MOI = 1 implies (if the Poisson distribution of virions per
cell is assumed) that 37% of cell will remain uninfected,
while only 26% of cell will be infected by more than 1 vir-
ion. Thus the observed 60% fraction of responding cells
implies that a single virus is enough to induce NF-κB
activity in a cell. Arnold et al. [49] analyzed responses of
peripheral blood mononuclear cells (PBMC) after expo-
sure to low infectious RSV doses, with MOI from 0.001 to
1. Even at MOI as low as 0.01–0.1 they observed pro-
nounced secretion of, NF-κB responsive cytokines like IL-
8, IL-6 and TNFα at 4 hours after infection.
System recovery: pulse-pulse experiment
Although several studies [23,25,45,50,51] have clarified
the relationship between time profile of IKK activity and
NF-κB oscillations, less is known about the regulation of
IKK activity itself. In response to TNF stimulation, IKK is
rapidly activated and then inactivated. As demonstrated
by the experimental findings [24] and modeling [23], an
important mechanism for this inactivation is mediated by
the NF-κB – A20 negative feedback loop. Here, a short
pulse of TNFα results in a brief peak of IKKa followed by
peak in nuclear NF-κB and burst of A20 mRNA and pro-
tein. The newly synthesized A20 attenuates IKK activity,
making the cell temporarily less sensitive to subsequent
TNFα stimulation. As described earlier, A20 acts via direct
and indirect mechanisms. Directly it binds to the regula-
tory subunit of IKK, speeding transformation of IKKa into
the inactive, hyperphosphorylated IKK (represented as
IKKi). Indirectly, it ubiquitinates RIP, a necessary compo-
nent of the active receptor complex leading to its specific
proteasomal degradation, thereby lowering the average
receptor activity. An interesting question arises: How
much time is needed for the system to recover, i.e., how
long should be the break after a brief TNFα pulse to allow
for the equal response to subsequent pulse? In order to
answer the question we performed an experiment (see
Additional file 1 for details of experimental protocol) in
which the population of 3T3 cells is stimulated by two
brief TNFα pulses (5 min., at 20 ng/ml) spaced at various
times apart ranging from 30 to 180 min. This saturating
TNFα concentration makes the individual cell responses
well synchronized, allowing for reliable population anal-
ysis, Fig 3. The IKK kinase activity is measured 5 min. after
the second pulse, and the IKK activity of the second peak
relative to the first is expressed as a function of break dura-
tion.
The experiment helped us to determine the parameters
governing the NF-κB – A20 – IKK negative feedback loop,
Figs 3G and 3H. Although after a short break the system
did not respond, full recovery of the system was observed
after 2.5 hours. Surprisingly, when the duration of the
break was extended to 3 hours the second peak of IKK
activity was higher than the first one. One could interpret
this result as the evidence that after 2.5 to 3 hours the cyto-
plasmic A20 concentration decreases to pretreatment val-
ues and some other protein is elevating IKK activity. One
of the candidates could be TRAF2, which is NF-κB respon-
sive and is a constituent of the TNFR1 receptor complex
[52]. To test this hypothesis we assume that at second
peak the activity of TNFα bound receptors is elevated 10
fold, Fig. 3I, and in fact this modification resulted in an
elevated IKK profile similar to the experimental findings.
However, since we do not find this a strong enough veri-
fication, we have not introduced this modification to the
current model.
Cell respond to stimulations by a wide range of TNFα 
doses
We performed the single cell stochastic numerical simula-
tions (SCSNS) of our model to analyze the individual cell
responses to persistent stimulation in a broad range of
TNFα doses. We assumed that there were 1000 TNFR1
receptors on cell surface, and each of these receptors
might be independently activated or inactivated, and that
the activation rate was proportional to the TNFα concen-
tration, which was kept constant during the experiment.
At a high TNFα dose (above 1 ng/ml) the receptor activa-
tion rate is high and most of cells are activated in the first
few minutes after the TNFα stimulation begins. As aPage 5 of 20
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Pulse-Pulse experimentFigure 3
Pulse-Pulse experiment. Panels A to F: IKKa and NF-κB oscillation amplitude resulting from single cell numerical simulations. 
Two TNFα (20 ng/ml), 5 min pulses are separated by 30', 60', 90' 120' 150' or 180' breaks. Four single cell simulations (marked 
by different colors) are shown in each panel. Panel G: IKK kinase activity in 3T3 cells stimulated by two 5 min. pulses of TNFα 
(20 ng/ml), separated by 30', 60', 90' 120' 150' or 180' break. First sub-blot corresponds to unstimulated cells, second sub-blot 
shows intensity of first peak, while next six sub-blots show the intensity of second peak as a function of brake duration, see 
Additional file 1 for the protocol of the experiment. Panels H and I magnitude of the second and the first peak of IKK and NF-
κB activity (nuclear NF-κB and IKKa) calculated from average over 500 cells. In numerical experiment presented in Panel I, the 
receptor activity coefficient ka was elevated 10 fold before second TNFα pulse.
BMC Bioinformatics 2007, 8:376 http://www.biomedcentral.com/1471-2105/8/376result, the first peak of IKK activity and the first peak of
NF-κB nuclear to cytoplasmic oscillation are well synchro-
nized among cells. Synchronization of subsequent peaks
of NF-κB oscillations decreases due to the stochastic proc-
esses of activation of TNFR1 receptors and A20 and IκBα
genes. Such behavior well agrees with Nelson et al. [33]
single cell experiment on SKNAS cells, Fig 4A versus 4B.
For low doses (0.1 and 0.03 ng/ml, Figs 4E and 4F), the
activation of each cell is typically due to the activation of
single receptor or a small number of receptors and thus
the first response time varies between cells. As a result, the
NF-κB oscillations are not synchronized at all. Moreover,
for the lowest dose (0.03 ng/ml, Fig 4F) the time span
between subsequent oscillations varies significantly. The
Single cell experiment and simulationFigure 4
Single cell experiment and simulation. Panel A: Nuclear-to-cytoplasmic NF-κB oscillations measured by Nelson et al. [33] 
shown for four SKNAS cells (marked by different colors) stimulated by 10 ng/ml TNFα. Panels B to F: IKKa and NF-κB oscilla-
tion amplitude resulting from model simulations, respectively for TNFα dose: 10, 1, 0.3, 0.1 and 0.03 ng/ml. In each panel we 
show three single cell simulations, marked by different colors.Page 7 of 20
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the cell become unstimulated. It is however possible that
dissociated TNFα molecule is immediately captured by
other TNFR1 receptors (or transiently by TNFR2 recep-
tors) of the same cell. This effect would keep the once
stimulated cell in semi-periodic oscillatory mode for the
longer time. Interestingly, the amplitude of the second
and subsequent oscillations is higher for the low TNFα
dose than for the high dose. This is due to the fact that at
a low TNFα dose the IKK activation proceeds not as fast:
the first peak of IKKa is smaller than for a high dose (Fig.
5) and more IKKn remains to be activated. As a result the
system at low dose stimulation exhibits subsequent IKKa
pulses followed by high NF-κB oscillations (Fig. 4).
Activation of a single TNFR1 receptor complex (trimer) 
turns on the NF-κB regulatory module
Mentioned earlier, the ability of the cell to respond to
femtomolar TNFα concentrations suggests that NF-κB reg-
ulatory module may be turned on by the single TNFα
trimer activating one TNFR1 receptor (receptor trimer).
According to our model the lower TNFα dose results in
lower probability of cell activation, but not in a much
weaker response in the responding cells (Figs. 5A and 6B).
We have chosen the receptors activation coefficient such
that 90% of cells are activated (have at least one receptor
active) in the first 10 minutes of TNFα stimulation by the
dose of 1 ng/ml, which may be treated as a saturation
dose, until the persistent stimulation is considered. This is
in agreement with experimental observations in which
responses to TNFα doses of 1 ng/ml or 10 ng/ml are
almost identical. Below this dose, the individual cell
responses become asynchronous and at any given
moment the population is a mixture of responsive and
nonresponsive cells.
Because the NF-κB regulatory network has the amplifica-
tion-saturation pathway build in, the final cell response
measured at the level of NF-κB responsive genes is about
the same in the case when the single receptor (trimer) is
activated as when 100 receptor complexes are activated.
To see how cell's response depends on the number of
active receptors, one can perform the following numerical
experiment. Let us assume that at t = 0, a given number N
(1, 3, 10, 30 or 100) of receptors is activated and that these
receptors remain active for 10 min. We traced the average
Characteristics of cell activation as a function of doseFigure 5
Characteristics of cell activation as a function of dose. Panel A: Probability of cell activation (at least one receptor activation) 
for 10 min. stimulation as a function of TNFα dose. Panel B: Cell activity measured as an average height of the IKKKa, IKKa, 
nuclear NF-κB, and A20mRNA peak resulting from 10 min. activity of 1, 3, 10, 30, or 100 receptors.Page 8 of 20
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κB, and A20 mRNA, Fig. 5B. We thus observed four levels
of signal saturation; first three are connected with the
transduction-amplification pathway, the last one with
gene regulation. According to our model the fivefold
decrease in peak IKK activity when we pass from 100 to 1
active receptor, does not result in much lower NF-κB oscil-
lation amplitude. This is in agreement with bulk of exper-
imental data suggesting that peak IKK activity at high and
intermediate TNFα dose of 10 or 1 ng/ml is much higher
than needed for efficient IκBα degradation. Specifically,
Lee et al. [24] demonstrated (for TNFα dose of 10 ng/ml)
that a very low IKK activity tail is sufficient to maintain
oscillations in IκBα level, and that a higher IKK activity
tail, typical for A20 deficient MEFs, totally suppress IκBα
accumulation. This result was confirmed by quantitative
data of Werner et al. [50] who stimulated A20 deficient,
immortalized 3T3 cells by a 45 minute long TNFα pulse at
a dose of 1 ng/ml. They found that the peak of IKK activity
(same for wild type and A20 -/- cells) was followed by tail
of fivefold lower magnitude but that this was enough to
keep most of NF-κB in the nucleus. The fact that NF-κB
remains nuclear implies high IκBα synthesis rate and thus
high degradation rate, so it may not accumulate to uptake
NF-κB back to cytoplasm.
The high sensitivity of NF-κB responses to low dose TNFα
stimulation has been already reported by Cheong et al.
[45] who, based on experiments with decreasing TNFα
dose from 10 to 0.01 ng/ml, concluded that NF-κB ampli-
tude is a logarithmic function of TNFα dose: It decreases
only twice as the doses changes from 10 to 0.1 ng/ml. The
effect we reported in Figs. 5B and 6B is even more dra-
matic, the NF-κB amplitude remains almost independent
of the TNFα dose assuming that only the activated cells
are considered. The single cell model we constructed sug-
gests that the decrease of NF-κB amplitude shown by
Cheong et al. [45] (Fig. 1) is at least partially due to pure
synchronization of cells. As recently experimentally dem-
onstrated by Sillitoe et al. [53] the averaging causes that
NF-κB pulses appear much smaller than they are. Sillitoe
et al. [53] experiment was performed for TNFα dose of 10
ng/ml, but even at that dose (at which one may expect
cells are relatively well synchronized) the first peak,
amplitude of the average trajectory is about twice smaller
than single cell amplitudes, and this difference is larger for
the second peak at which cells are less synchronized. In
addition, at the smallest dose of 0.01 ng/ml studied by
Cheong et al. [45], which corresponds to only 1/4 of
TNFα trimer per cell volume, we observe the effect of aver-
aging over responsive and nonresponsive cells, which
lowers the amplitude of average NF-κB trajectory.
There is still not enough experimental data at single cell
level to uniquely determine how each step of transduction
amplification cascade contributes to amplification.
Cheong et al. [45] attempted to address this question
based on population data and found that a 100 fold
decrease of TNFα dose from 10 to 0.1 ng/ml results in a
fourfold decrease of IKK activity peak and in a twofold
decrease of NF-κB amplitude. As already discussed, the
population data can be quite misleading, and in fact to fit
to this data Cheong et al. [45] had to assume time depend-
ent IKK activation and inactivation rates. Such approach
seems artificial and cannot be applied to more general
protocols of TNFα stimulation (e.g., to pulse-pulse stimu-
lation).
As discussed above, the constructed model has the prop-
erty that the stable activity of a single receptor is sufficient
to turn on the NF-κB regulatory module and trigger the
transcription of NF-κB dependent genes. Although the
experimental data suggests that the a very limited number
of active receptors is needed to induce NF-κB activity,
there is no evidence that activity of a single receptor is suf-
ficient. One may expect that there exists a threshold of the
number of active receptors (receptor complexes) needed
for cell activation. In the case of T-cells stimulation, it was
experimentally demonstrated [15] that just three major
peptide histocompatibility complexes are required to
induce T-cell cytotoxic activity. T-cell receptor signalling
involves MAPK kinase cascade [54], which can convert
graded inputs into switch-like outputs [55]. Both MAPK
and MAPKK require two phosphorylations to become
fully activated, and this dual phosphorylation is a source
of nonlinearity in signal processing, which together with
saturation (with a strong signal all MAPK is phosphor-
ylated) results in a switch-like output.
Since we did not identify any simple mechanisms defin-
ing the threshold here, we followed the simplest possibil-
ity and assumed that amplification provided by the
TNFR1-IKKK-IKK-IκBα cascade is high enough to cause
that activation of a single receptor is sufficient to induce
cell activity. To rule out or confirm the competitive thresh-
old hypothesis it is worth to consider a series of single cell
experiments, in which cells would be stimulated for 5
min. with a decreasing TNFα dose, and measure the frac-
tion of responding cells. Pulse stimulation would help
localize activation and response to relatively short time
periods.
According to our model, the probability that a single
receptor is activated by a TNFα stimulation lasting for
time t at a concentration C is equal to
pr1(C) = 1 - exp(-kbCt), (1)
where kb is the receptor activation rate. Thus, if activation
of a single receptor is sufficient to activate the cell, thenPage 9 of 20
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imately linearly with TNFα concentration C for low con-
centrations C. If however, at least n receptors must be
activated in order to activate the cell then the probability
of cell activation would be equal to prn
where N is total number of receptors and kbn is the new
hypothetical TNFα binding constant. In such case the frac-
tion of responding cells F would decrease faster, approxi-
mately as Cn (for small C). In Fig. 6A we compare model
predictions (n = 1, red line) against threshold hypothesis
(n = 3, green line) and (n = 10, black line) for N = 1000.
Activation probability functions pr3(C) and pr10(C) are
normalized by adjusting activation rates kb3  5.03 kb and
kb10  20.79 kb, what assures that all prn(C) functions
intersect at the same point at which prn(C) = 1/3.
The single pulse, low dose, experiment would also enable
us to determine the "minimum cell response" as the aver-
age (over subpopulation of responding cells) NF-κB oscil-
lation amplitude for very small C. According to our model
(Fig. 6B) such a minimum response exists and moreover
it is high enough to assure unequivocal expression of NF-
κB responsive genes in majority of responding cells.
Conclusion
Stochastic gene activation (leading to the burst of pro-
teins) and stochastic cell activation (leading to the mas-
sive NF-κB nuclear translocation) leads to what might be
called "stochastic robustness" in cell regulation. If a given
gene is activated, a large burst of proteins is produced, in
order to assure a sufficient level of activity of these pro-
teins. Stochastic robustness assures the minimal response
to the signal. Decreasing magnitude of the signal mostly
reduces the probability of response, which leads to a
smaller fraction of responding cells. This may be a useful
strategy: If the TNFα signal is low, some cells respond by
a massive NF-κB translocation, whereas some do not
respond at all. It helps to avoid ambiguity, such as when
a small nuclear concentration of NF-κB leads to activation
of an undefined fraction of NF-κB responsive genes. Such
an ambiguous response might do more harm than good.
In fact the all-or-none responses arising due to ultrasensi-
tivity and saturation or bistability (typically connected
with positive feedbacks) have been reported for various
signalling elements: TCR signaling [54], Xenopus p42
MAPK cascade [55], transduction cascade JNK in oocytes
[56], and Lac operon, e.g. [57]. The growing evidence of
bistability in various system may suggest that it is a good
strategy for regulation at the tissue level.
Stochastic robustness allows cells to respond differently to
the same stimulation, but makes their individual
responses better defined. Both effects could be crucial in
early immune response: Diversity in cell responses causes
the tissue defense to be harder to overcome by relatively
simple programs coded in viruses and other pathogens.
The more focused single cell responses help cells to decide
their individual fates such as proliferation or apoptosis.
The stochastic model proposed by us explains the mecha-
nisms of TNFα cell activation at nanomolar concentra-
tions when the number of molecules of activation factor
per cell is very limited. In the example of TNFα diffusion
in the tissue, considered by Cheong et al. [45], concentra-
tion of 0.01 ng/ml or 200 fM corresponds to less than one
TNFα trimer per cell. In such case population consists of
responding and nonresponsive cells, and the output






















Model predictions for pulse low dose TNFα stimulationFigure 6
Model predictions for pulse low dose TNFα stimulation. 
Panel A: Probability of cell activation during 5 min. long 
TNFα stimulation as a function of dose, model prediction 
(red) versus threshold hypothesis: green (3 receptors), black 
(10 receptors). Panel B: Average height of nuclear NF-κB 
peak calculated for subpopulation of N = 500 of activated 
cells (at least with one receptor activated) after 5 min. long 
TNFα stimulation as a function of TNFα dose.
TNFα dose [ng/ml]
[A]
TNFα dose [ng/ml]Page 10 of 20
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ual cell evolves like the average and the average does not
correspond to any biological process. This means that the
model build to follow the average trajectory in general
may not be correct. Despite this fact, the experimental
average may be useful when compared with the average of
many single cell stochastic simulations. Predictions from
our model agree qualitatively with large set of population
data (see Additional file 3: Figs S1, S2, S3 and S4) includ-
ing the Cheong et al. [45] experiment in which IKK and
NF-κB activity were measured across a wide range of TNFα
concentrations, Fig. 7.
The proposed model supports hypothesis that at nanomo-
lar concentrations NF-κB activity results from binding of
single TNFα trimers. Such hypersensitivity of NF-κB regu-
latory module may be the only way to detect and respond
to single viruses invading cells and to allow for cytokine
extracellular signaling.
Methods
Stochastic NF-κB model with two feedback loops
The model applied involves two-compartment kinetics of
NF-κB and its inhibitors A20 and IκBα, and allows analyz-
ing single cell responses to TNFα stimulation of arbitrary
and time dependent intensity, in both wild type and A20
deficient cells. It combines our previous model [35] with
the signal transduction-amplification cascade, which
transmits the signal from the TNFR1 receptors, [30], to the
NF-κB-IκBα-A20 regulatory module. The single event of
receptor activation is amplified by the three-step signal
transduction cascade involving activation of kinase
named IKKK (IKK activating kinase) and IKK [30]. Biolog-
ically, there are at least two kinases involved in this proc-
ess: MEKK3 [58,59] and TAK1 [59-61]. Shim et al. [61]
showed that TAK1 mediates IKK activation in TNFα and
IL-1 signaling pathways. Homozygous mutants (Tak1m/m)
do not show NF-κB activity under TNFα stimulation, and
exhibit lowered NF-κB activity than the wild type cells in
Average IKK and NF-κB activity (nuclear NF-κB and IKKa) as function of TNFα dose, model versus Cheong et al. 2006 exper-im nt [45]Figure 7
Average IKK and NF-κB activity (nuclear NF-κB and IKKa) as function of TNFα dose, model versus Cheong et al. 2006 exper-
iment [45]. Panels A: IKKa and IKK kinase activity, Panel B: nuclear NF-κB calculated as average of N single cell simulation: N = 
50 for TNFα dose equal 10 ng/ml, N = 100 (1 ng/ml), N = 500 (0.1 ng/ml) and N = 2500 (0.01 ng/ml). and EMSA assays of 
nuclear NF-κB. To compare our predictions to experimental data, we rescale the time coordinate, i.e. we calculate the values 
of corresponding functions in the same time points as in the experiment. Despite the qualitative agreement between the model 
and the experiment shown there is substantial difference in IKK activity peak timing and smaller difference in NF-κB profile 
timing for 10 ng/ml dose. In fact there is also large discrepancy between different experiments; here the IKK activity peak is 
observed for 5 min., while in [50] for 10 min. and in [62] for 15 min.Page 11 of 20
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MEKK3 by siRNA reduces IKK activity. These two findings
and the experiment by Blonska et al. [59] suggest that
TAK1 is recruited to the TNFR1 complex via RIP and likely
cooperates with MEKK3 to activate NF-κB in TNFα signal-
ing. In our model we mimic this possibly complex trans-
duction mechanism by a single entity: IKKK. To
accomplish the above, we assume that IKKK migrates
toward the receptor and is activated at a receptor (transfor-
mation from IKKKn to IKKKa). Active IKKKa molecules
activate IKK molecules (transformation from IKKn to
IKKa) which in turn phosphorylate IκBα molecules lead-
ing to their ubiquitination and degradation. It is assumed
that the total number of IKKK and IKK molecules (as well
as of the NF-κB molecules) is constant; i.e., their degrada-
tion is balanced by production, but both terms are omit-
ted in the mathematical representation. The IKKK
molecules may exist in one of two states,
• native, neutral, IKKKn, specific to unstimulated resting
cells without, and
• active IKKKa.
The activity of IKKK is very transient, i.e., it is activated
rapidly (with the maximum rate 1/s from single active
receptor) and inactivated with the half time of about 1
min.
IKK complexes, consisting of catalytic subunits IKKα and
IKKβ and regulatory subunits IKKγ, may exist in one of
four states,
• native neutral (denoted by IKKn), specific to unstimu-
lated resting cells.
• active (denoted by IKKa), arising from IKKn via phos-
phorylation of serines 177 and 181 of IKKβ subunits [62]
upon the IKKKa induced activation,
• inactive (denoted by IKKi), but different from the native
neutral form, arising from IKKa possibly due to overphos-
phorylation, and
• transient between IKKi and IKKn, also inactive, denoted
by IKKii.
The activation pathway considered, which involves
kinases IKKK and IKK, resembles the one introduced by
Park et al. [30]. The main difference is that we take into
account the inactivation of IKKa is due to its transforma-
tion to the state IKKi different from the native state IKKn.
As a result, in contrast to Park et al. model [30], the tonic
TNFα stimulation induces transient IKK activity in agree-
ment with the experimental data, Figs 6 and S2.
In resting cells, the unphosphorylated IκBα binds to NF-
κB and sequesters it in an inactive form in the cytoplasm.
IKKa mediated phosphorylation of IκBα leads to it degra-
dation and releases the main activator NF-κB, which then
enters the nucleus and triggers transcription of the two
inhibitors and numerous other genes. The newly synthe-
sized IκBα leads NF-κB out of the nucleus and sequesters
it in the cytoplasm.
IKK inactivation is controlled by the second inhibitor
A20, which like IκBα; is strongly NF-κB responsive [22].
The exact mechanism of A20's action is still not fully
resolved. Here we assume that A20 acts in two ways: (1) It
initiates degradation of RIP, the key component of the
TNFR1 receptor complex [63], which attenuates the activ-
ity of receptors, and (2) it directly associates with IKKγ
[64], enhancing IKKa conversion (this conversion takes
place also in A20 deficient cells but at a slower rate) to cat-
alytically inactive form IKKi. The exact mechanism of IKK
inactivation remains unresolved: According to Delhase et
al. [62] IKK inactivates via autophosphorylation of serines
in IKKβ C-terminal region. However, recently Schomer-
Miller et al. [65] found that this autophosphorylation
does not diminish IKK activity and suggested that phos-
phorylation of serines 740 and 750 in NBD/γBD domain
of IKKβ may have a regulatory role and that their phos-
phorylation may downregulate IKK activity. The form
IKKi spontaneously converts into IKKn through inactive
intermediate forms collectively denoted by IKKii. The
number of these forms may be large since there are at least
16 serine residues in IKKβ [65], which may be involved in
regulation of IKK activity. This intermediate step is intro-
duced in the model to account for the delay needed to
process the inactivated form IKKi into native state IKKn.
This effect is manifested in A20-/- cells (at persistent or
long lasting TNFα stimulation) as a downregulation of
IKK activity at about 30 min. followed by a higher plateau
(Figs. S2 and S3, reproduced after [24] and [50] experi-
ments). According to our model in the first minutes of
high dose TNFα stimulation most of IKKn is used up so
the IKK activation rate is low, only after some IKKn is
recovered via intermediated form IKKii, the activation rate
and the level of IKKa may increase.
The inhibitor IκBα migrates between the nucleus and
cytoplasm and forms complexes with NF-κB molecules.
The nuclear IκBα|NF-κB complexes quickly migrate into
the cytoplasm. The second inhibitory protein A20 is con-
sidered only in the cytoplasm where it triggers the inacti-
vation of IKK. It is assumed that the transformation rate
from IKKa into IKKi is the sum of the constant term and a
term proportional to the amount of A20.
The transcriptional regulation of A20 and IκBα genes is
governed by the same rapid elongation regulatory mecha-Page 12 of 20
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transcription. The mechanisms for NF-κB dependent reg-
ulation of IκBα and A20 are based on the control of tran-
scriptional elongation. In this situation, stalled RNA
polymerase II is rapidly activated by NF-κB binding to
enter a functional elongation mode, and requires contin-
ued NF-κB binding for reinitiation. This is represented in
our model by tight coupling of NF-κB binding to mRNA
transcription. We assume that all cells are diploid, and
both A20 and IκBα genes have two potentially active
homologous copies, each of which is independently acti-
vated due to binding of NF-κB molecule to a specific reg-
ulatory site in gene promoter. Following [1,3,8,35] and
others we made the simplifying assumption that each
gene copy may exist only in one of two states; active and
inactive. When the copy is active the transcription is initi-
ated at a high rate, when the copy is inactive transcription
is inhibited. The gene copy becomes inactive when the
NF-κB molecule is removed from its regulatory site due to
the action of IκBα molecules, which bind to DNA-associ-
ated NF-κB, exporting it out of the nucleus.
In this work, as in our recent papers [35] we follow the
method proposed by Haseltine and Rawlings [66] and
split the reaction channels into fast and slow. We consider
all reactions involving mRNA and protein molecules as
fast and the reactions of receptors and genes activation
and inactivation as slow. Fast reactions are approximated
by the deterministic reaction-rate equations, whereas slow
reactions are considered stochastic.
According to the above, the mathematical model consists
of 15 ordinary differential equations (ODEs) accounting
for
• formation of the (IκBα|NF-κB) complexes,
• IKKK and IKK kinase activation and inactivation
• IKKa driven IκBα phosphorylation,
• A20, IκBα and phospho-IκBα proteins degradation
• transport between nucleus and cytoplasm, and
• transcription and translation.
All the substrates are quantified by the numbers of mole-
cules. The upper-case letters denote substrates or their
complexes. Nuclear amount is represented by subscript n,
while subscript c denoting amount of substrate in the
cytoplasm is omitted, to simplify the notation. Amounts
of the mRNA transcript of A20 and IκBα are denoted by
subscript t:
Notation guide
• IKKn – neutral form of IKK kinase,
• IKKa – active form of IKK,
• IKKi – inactive form of IKK,
• IKKii – inactive intermediate form of IKK,
• KNN – total number of IKK = IKKn+IKKa+IKKi+IKKii
molecules (assumed to be constant in time)
• IKKKa – amount of active form of IKKK,
• IKKKn – amount of neutral form of IKKK,
• KN – total number of IKKK=IKKKn+IKKKa molecules
(assumed to be constant in time)
• IκB – cytoplasmic amount of IκBα,
• IκBn – nuclear IκBα,
• IκBt – IκBα mRNA transcript,
• IκBp – phosphorylated cytoplasmic IκB
• NFκB|IκB – cytoplasmic (NF-κB|IκBα) complexes
• NFκB|IκBp – phosphorylated cytoplasmic IκBα com-
plexed to NFκB
NFκB|IκBn – nuclear (NFκB|IκBα) complexes
• TNF – TNFα concentration,
• GIκB – discrete random variable, state of IκBα gene,
• GA20 – discrete random variable, state of A20 gene,
• kv = V/U – ratio of cytoplasmic to nuclear volume.
• B – number of active receptors, M – total number of
receptors (assumed to be constant in time)
IKKK in active state (IKKKa)
The first term describes IKKK kinase activation, i.e. trans-
formation from IKKKn (amount of which is IKKKn = KN -
IKKKa) due to action of active receptors B(t), whose activ-
ity is attenuated by A20. The second term describes spon-
taneous inactivation of the kinase
d
dt
IKKKa t k k k A B t K IKKKa t k IKKKaa a a N i( ) /( ) ( ) ( ( ))= × + × × − − ×20 20 20 ( ).t
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The first term describes IKKn recovery from the intermedi-
ate form IKKii (amount of which is IKKii = KNN - IKKn -
IKKa - IKKi), whereas the second term describes depletion
of IKKn due to its transformation into IKKa mediated by
IKKKa
IKK in the active state IKKa
The first term represents transition from IKKi to IKKa
mediated by IKKKa, whereas the second term represents
depletion of IKKa due to its transformation into inactive
form IKKi mediated by A20
IKK in the inactive state IKKi
The first term corresponds to the formation of inactive
IKKi from IKKa by A20 mediated inactivation, whereas
the second term describes transformation into IKKii
Phospho-IκBα (IκBp)
The first term describes IκBα phosphorylation due to cat-
alytic action of IKKa, the second term catalytic degrada-
tion of phosphorylated IκBα
Phospho-IκBα complexed to NF-κB (NFκB|IκBp)
The first term describes IκBα phosphorylation (in com-
plexes with NF-κB) due to the catalytic action of IKKa, the
second term catalytic degradation of phosphorylated IκBα
(NF-κB is recovered)
Free cytoplasmic NF-κB
The first two terms represents liberation of free NF-κB due
to degradation of IκBα in (IκBα|NF-κB) complexes and its
depletion due to formation of these complexes. The third
term accounts for liberation of NF-κB due to degradation
of phospho-IκBα. The last term describes transport of free
cytoplasmic NF-κB to the nucleus,
Free nuclear NF-κB
The first term describes transport into the nucleus. The
second term represents depletion of free nuclear NF-κB
due to the association with nuclear IκBα and is adjusted,
by multiplying the synthesis coefficient a1 by kv = V/U, to
the smaller nuclear volume resulting in a larger concentra-
tion,
A20 protein
Described by its mRNA synthesis and constitutive degra-
dation,
A20 transcript
The first term stands for NF-κB inducible synthesis, while
the second term describes degradation of the A20 tran-
script,
Free cytoplasmic IκBα protein
The first term accounts for IKKa induced phosphorylation,
the second for NF-κB binding. The second line describes
IκBα synthesis and the constitutive degradation of IκBα.
The last two terms represent transport into and out of the
nucleus,
Free nuclear IκBα protein
The first term corresponds to IκBα association with
nuclear NF-κB (adjusted, by multiplying the synthesis
coefficient a1 by kv, for the smaller nuclear volume result-
ing in larger concentration), and the last two terms repre-
sent the transport into and out of the nucleus,
d
dt
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The first term stands for NF-κB inducible synthesis,
whereas the second term describes degradation of IκBα
transcript
Note that Eq. (15) (as well as 12) naturally produces sat-
uration in transcription speed. When the nuclear amount
of regulatory factor NF-κB is very large, then the binding
probability is much larger than the dissociation probabil-
ity, and the gene state would be Ga = 2 for most of the
time. In such case the transcription would proceed at a
maximum rate, 2c1.
Cytoplasmic (IκBα|NF-κB) complexes
The first line describes formation of the complexes due to
IκBα and NF-κB association and their degradation. The
first term in the second line represents phosphorylation of
the (IκBα|NF-κB) complexes due to the catalytic activity
of IKKa. The last term represents transport of the complex
from the nucleus,
Nuclear (IκBα|NF-κB) complexes
Described by their formation due to IκBα and NF-κB asso-
ciation (adjusted, by multiplying the synthesis coefficient
a1 by kv, to the smaller nuclear volume resulting in larger
concentration) and their transport out of the nucleus,
Propensities of receptors and genes activation and 
inactivation
The receptors activate and inactivate independently with
activation propensity  proportional to the TNFα(t)
concentration (which may be time dependent) and inac-
tivation propensity  constant
We assume that both A20 and IκBα genes have two
homologous copies independently activated due to NF-
κB binding, and inactivated due IκBα mediated removal
of NF-κB molecules, and that binding and dissociation
propensities rb(t) and rd(t), respectively, are equal for each
copy:
rb(t) = q1 × NFκBn(t),  rd(t) = q2 × IκBαn(t). (19)
The state of gene copy Gi (i = 1, 2) is Gi = 1 whenever NF-
κB is bound to the promoter regulatory site, and Gi = 0
when the site is unoccupied. As a result the gene state G =
G1 + G2 can be equal to 0, 1 or 2. In this approximation the
stochasticity of single cell kinetics solely results from dis-
crete regulation of receptors activity and transcription of
A20 and IκBα genes.
In model computations, the amounts of all the substrates
are expressed as the numbers of molecules. Since we use
the ODE's to describe most of the model kinetics,
amounts of molecules are not integer numbers, but since
these numbers are in most cases much greater than 1, such
description is reasonable.
Numerical implementation
The numerical scheme implemented follows that of [35]:
(1) At simulation time t; for given states
 of the A20
and IκBα genes, and number of active (bound) receptors
B (M is the total number of receptors) we calculate the
total propensity function r(t) of occurrence of any of the
activation and inactivation reactions
(2) We select two random numbers p1 and p2 from the uni-
form distribution on [0, 1].
(3) Using the fourth order MATLAB solver we evaluate the
system of 15 ODEs accounting for fast reactions, until
time t + τ such that
(4) There are 6 potentially possible different reactions:
• receptor may be activated or inactivated. Typically in
time course there are many inactive receptors which may
activated and active receptors which may be inactivated,
but since the receptors are assumed to be identical it is not
important which one of them changes its state.
• NF-κB may bind to or dissociate from any of two alleles
of A20 and IκBα genes.
d
dt
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sible reactions occurs at time t+τ using the inequality
where ri(t + τ), i = 1,...,6 are individual reaction propensi-
ties and k is the index of the reaction to occur.
(5) Finally time t + τ is replaced by t, and we go back to
item (1).
In all simulations before TNFα stimulation starts, we sim-
ulate a resting cell for time t randomly chosen from the
interval of 15 to 25 hours in order to get equilibrated and
randomized initial conditions. As shown in [35] the rest-
ing cells oscillate. Due to natural degradation of IκBα,
some NF-κB molecules may occasionally enter the
nucleus and activate the A20 or IκBα gene, which results
in bursts of A20 and IκBα mRNAs and proteins. As a result
the initial (at t = 0) level of A20 or IκBα mRNA and pro-
tein differs across the population, which influences future
cells evolution.
In Figs. 8 and 9 we present evolution of selected variables
during the persistent TNFα stimulation at high (10 ng/ml)
and low (0.1 ng/ml) dose. We show both a single cell evo-
lution and the average over 100 cells. The average is used
to validate the model based on population data (Figs 3, 4,
7 and Figs S1, S2, S3, S4 in Additional file 3).
To compare model predictions with Nelson et al. experi-
ment [33] we calculate the NF-κB nuclear to cytoplasmic
oscillation amplitudes assuming that 40% of total pool of
NF-κB does not oscillate, Fig. 4. We also convert ratio of
nuclear to cytoplasmic amounts to ratio of light intensi-
ties, making use of the fact that nucleus is smaller than
cytoplasm. These two operations do not influence the
character of the oscillations but only their amplitude. The
non-oscillatory fraction (not taken in account in the
model) remains in the cytoplasm even after all IκBα is
degraded. This fraction is observed also in population
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Evolution of main variables during persistent, 10 hours long stimulation with high dose TNFα = 10 ng/mlFigure 8
Evolution of main variables during persistent, 10 hours long stimulation with high dose TNFα = 10 ng/ml. Red line – typical sin-
gle cell simulation, black line – average over 100 cells. Panel A: Number of active receptors, Panel B: IKKKa level, Panel C: IKKa 
level, Panel D: Total IκBα, Panel E: Nuclear NF-κB, Panel F: IκBα gene activity, Panel G: A20 gene activity, Panel H: IκBα 
mRNA, Panel I: A20 mRNA, Panel J: A20 protein.Page 16 of 20
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NF-κB bound to other IκBα isoforms and of NF-κB mole-
cules with nuclear localization sequence damaged.
Model fitting and parameters
The model is intended. cells showing oscillations in NF-
κB nuclear-to-cytoplasmic localization under persistent
TNFα stimulation. We do not to fit the parameters to any
given single experiment but we intuitively choose the set
of parameters which produces qualitative agreement with
a major subset of existing data. Quantitative agreement is
not possible because there is a substantial discrepancy
mostly in IKK activity and NF-κB peak timing between
experiments). Because of a large number of undetermined
parameters, this is a tedious task, but in our opinion it is
better to produce a model in qualitative agreement with
the current and previous experiments, than a model per-
fectly fitted to a single experiment with limited set of data.
We based our choice of parameters on both single cell and
population experiments. In the letter case, to compare our
model with experiments, we average a large number of
single-cell stochastic simulations. This procedure is much
more time consuming that comparing the deterministic
model with the population data, but as already shown (in
the case of low dose TNFα stimulation) the population
data do not correspond to any biological process, and
thus constructing the model fitted to such a data is not jus-
tified.
We applied the following method of choosing the values
of parameters:
1) Start from a reasonable set of parameters, which pro-
duces a correct steady state in the absence of TNFα signal.
2) Proceed with the signal initiated by TNF downstream
the autoregulatory loops.
3) Iterate item 2 until the fit to all the data is satisfactory.
The TNFα signal first causes activation of receptors then
transformation of IKKKn into IKKKa which catalyses
transformation of IKKn into IKKa. In turn, IKKa catalyses
degradation of cytoplasmic (IκBα|NF-κB); enabling the
free NF-κB to enter the nucleus. Once NF-κB builds up in
the nucleus it upregulates the transcription of the A20 and
Evolution of main variables during persistent, 10 hours long stimulation with low dose TNFα = 0.1 ng/ml, see Fig. 8 for descrip-tionFigure 9
Evolution of main variables during persistent, 10 hours long stimulation with low dose TNFα = 0.1 ng/ml, see Fig. 8 for descrip-
tion. Note, that at low dose stimulation first IKKa peak is smaller than for high dose but the subsequent peaks are well pro-
nounced. As a result subsequent NF-κB oscillations are higher for low than high dose.Page 17 of 20
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mation of IKKa into IKKi and blocks the receptors, while
IκBα enters the nucleus, binds to NF-κB and leads it into
cytoplasm. As stated in item 2, we first fit the coefficients
regulating IKK activation (using data on IKK activity),
then the coefficients regulating degradation of the cyto-
plasmic (IκBα|NF-κB) and IκBα degradation and so forth.
If there were no feedback loops in the pathway, the pro-
posed method would be quite efficient, but, since they
exist, it is necessary to iterate the signal tracing several
times, until the fit is satisfactory. Once a satisfactory set of
parameters is found, we observe that this set of parameters
is not unique. This ambiguity is mainly caused by the lack
of measurements of absolute values of protein or mRNA
amounts. The action exerted by some components of the
pathway onto the rest of the pathway is determined by
their amounts multiplied by undetermined coupling coef-
ficients. Hence, once we have a good set of parameters, we
may obtain another one using a smaller coupling coeffi-
cient and by proportionately enlarging the absolute level
of the component. Since not all parameters may be deter-
mined based on existing data we have assumed values of
part of parameters mostly based on our intuition and fit-
ted the remaining ones. By such approach we show how
much information can be inferred from available experi-
mental data. Ambiguity in parameter determination leads
to significant differences between parameters of our
model and the corresponding parameters chosen by oth-
ers groups of researcher. Values of all model parameters
are listed in discussed in detail in Additional file 2.
The validation of the proposed model, is based on our
data (see Fig. 3) in addition to [33] (see Fig. 4), [45] (see
Fig. 7), [28] (see Additional file 3: Fig. S1), [24] (see Addi-
tional file 3: Fig. S2), [50] (see Additional file 3: Fig S3),
[34] (see Additional file 3: Fig S4) and [62] experiments.
Typical experimental data at our disposal consist of meas-
urements made at time points that are not uniformly dis-
tributed. Therefore, to compare our predictions to
experimental data, we rescale the time coordinate, i.e. we
calculate the values of corresponding functions in the
same time points as in the experiment, and then to guide
the eye we connect the resulting discrete points by
straight-line segments, thus obtaining a saw-like graph.
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